Jørgen Hilden

发表

A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index

Thomas A Gerds, Jørgen Hilden, J. Hilden, 2014, Statistics in medicine.

What properties should an overall measure of test performance possess?

Jørgen Hilden, J. Hilden, 2005, Clinical chemistry.

Calibration of models is not sufficient to justify NRI.

Thomas A Gerds, Jørgen Hilden, 2014, Statistics in medicine.

Modeling In Medical Decision Making. A Bayesian Approach.Giovanni Parmigiani, Wiley, Chichester, 2002. No. of pages: xi + 267. Price: £45.00. ISBN 0‐471‐98608‐9

Jørgen Hilden, 2003 .

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Holly Janes, Ziding Feng, Margaret S Pepe, 2016, Clinical chemistry.

[Measures for the performance of diagnostic tests].

Jørgen Hilden, Bo Rud, Peter Matzen, 2005, Ugeskrift for laeger.

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies.

Ann Sofia Skou Thomsen, Asbjørn Hróbjartsson, Jørgen Hilden, 2014, International journal of epidemiology.

The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement with Miscalibrated or Overfit Models

Thomas A. Gerds, Ziding Feng, Margaret S. Pepe, 2013 .

Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial

Christian Gluud, Morten Damgaard, Jørgen Hilden, 2005, BMJ : British Medical Journal.

Commentary: On NRI, IDI, and "good-looking" statistics with nothing underneath.

Jørgen Hilden, J. Hilden, 2014, Epidemiology.

Analysing how we reach clinical decisions Huw Llewelyn and Anthony Hopkins, Royal College of Physicians of London, London, 1993. No. of pages: xii + 166. Price £18.95. ISBN 1‐873240‐68‐6

Jørgen Hilden, 1994 .

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

Peter C Gøtzsche, Jørgen Hilden, J. Hilden, 2006, BMJ : British Medical Journal.

Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial.

Christian Gluud, Jørgen Hilden, J. Hilden, 2011, Atherosclerosis.

Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

Isabelle Boutron, Philippe Ravaud, Ann Sofia Skou Thomsen, 2012, BMJ : British Medical Journal.